检索结果 - Jan Vilsvik

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer

    Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer 由 Christian von Plessen, Bengt Bergman, Olga Andresen, R. M. Bremnes, Stein Sundstrøm, M Gilleryd, RJ Stephens, Jan Vilsvik, Ulf Aasebø, S Sörenson

    出版 2006
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Irinotecan Plus Carboplatin Versus Oral Etoposide Plus Carboplatin in Extensive Small-Cell Lung Cancer: A Randomized Phase III Trial

    Irinotecan Plus Carboplatin Versus Oral Etoposide Plus Carboplatin in Extensive Small-Cell Lung Cancer: A Randomized Phase III Trial 由 Andreas Hermes, Bengt Bergman, Roy M. Bremnes, Lars Ek, Sverre Fluge, Christer Sederholm, Stein Sundstrøm, Lars Thaning, Jan Vilsvik, Ulf Aasebø, Sverre Sörenson

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: